Literature DB >> 15249223

Effect of metal ions on de novo aggregation of full-length prion protein.

Armin Giese1, Johannes Levin, Uwe Bertsch, Hans Kretzschmar.   

Abstract

It is well established that the prion protein (PrP) contains metal ion binding sites with specificity for copper. Changes in copper levels have been suggested to influence incubation time in experimental prion disease. Therefore, we studied the effect of heavy metal ions (Cu(2+), Mn(2+), Ni(2+), Co(2+), and Zn(2+)) in vitro in a model system that utilizes changes in the concentration of SDS to induce structural conversion and aggregation of recombinant PrP. To quantify and characterize PrP aggregates, we used fluorescently labelled PrP and cross-correlation analysis as well as scanning for intensely fluorescent targets in a confocal single molecule detection system. We found a specific strong pro-aggregatory effect of Mn(2+) at low micromolar concentrations that could be blocked by nanomolar concentration of Cu(2+). These findings suggest that metal ions such as copper and manganese may also affect PrP conversion in vivo.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15249223     DOI: 10.1016/j.bbrc.2004.06.075

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  22 in total

1.  Two different binding modes of α-synuclein to lipid vesicles depending on its aggregation state.

Authors:  Tobias Högen; Johannes Levin; Felix Schmidt; Mario Caruana; Neville Vassallo; Hans Kretzschmar; Kai Bötzel; Frits Kamp; Armin Giese
Journal:  Biophys J       Date:  2012-04-03       Impact factor: 4.033

Review 2.  Role of manganese in neurodegenerative diseases.

Authors:  Aaron B Bowman; Gunnar F Kwakye; Elena Herrero Hernández; Michael Aschner
Journal:  J Trace Elem Med Biol       Date:  2011-10-01       Impact factor: 3.849

Review 3.  Using NMR spectroscopy to investigate the role played by copper in prion diseases.

Authors:  Rawiah A Alsiary; Mawadda Alghrably; Abdelhamid Saoudi; Suliman Al-Ghamdi; Lukasz Jaremko; Mariusz Jaremko; Abdul-Hamid Emwas
Journal:  Neurol Sci       Date:  2020-04-24       Impact factor: 3.307

4.  A mechanism for copper inhibition of infectious prion conversion.

Authors:  Daniel L Cox; Jianping Pan; Rajiv R P Singh
Journal:  Biophys J       Date:  2006-05-12       Impact factor: 4.033

5.  The configuration of the Cu2+ binding region in full-length human prion protein.

Authors:  Pablo del Pino; Andreas Weiss; Uwe Bertsch; Christian Renner; Matthias Mentler; Klaus Grantner; Ferdinando Fiorino; Wolfram Meyer-Klaucke; Luis Moroder; Hans A Kretzschmar; Fritz G Parak
Journal:  Eur Biophys J       Date:  2007-01-16       Impact factor: 1.733

Review 6.  Insights into prion protein function from atomistic simulations.

Authors:  Miroslav Hodak; Jerzy Bernholc
Journal:  Prion       Date:  2010-01-16       Impact factor: 3.931

7.  Infectious prion protein alters manganese transport and neurotoxicity in a cell culture model of prion disease.

Authors:  Dustin P Martin; Vellareddy Anantharam; Huajun Jin; Travis Witte; Robert Houk; Arthi Kanthasamy; Anumantha G Kanthasamy
Journal:  Neurotoxicology       Date:  2011-08-19       Impact factor: 4.294

8.  Copper alters aggregation behavior of prion protein and induces novel interactions between its N- and C-terminal regions.

Authors:  Abhay Kumar Thakur; Atul Kumar Srivastava; Volety Srinivas; Kandala Venkata Ramana Chary; Chintalagiri Mohan Rao
Journal:  J Biol Chem       Date:  2011-09-07       Impact factor: 5.157

9.  Normal cellular prion protein protects against manganese-induced oxidative stress and apoptotic cell death.

Authors:  Christopher J Choi; Vellareddy Anantharam; Nathan J Saetveit; Robert S Houk; Arthi Kanthasamy; Anumantha G Kanthasamy
Journal:  Toxicol Sci       Date:  2007-05-04       Impact factor: 4.849

Review 10.  Recent advances in prion chemotherapeutics.

Authors:  Valerie L Sim; Byron Caughey
Journal:  Infect Disord Drug Targets       Date:  2009-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.